menu search

Clearside biomedical completes recruitment in odyssey phase 2b clinical trial of cls-ax in wet amd

– Successful Completion of Recruitment Driven by Strong Clinical Site Participation and Investigator Support – – Topline Data Expected in Q3 202...

November 1, 2023, 11:05 am

Apellis pharmaceuticals reports third quarter 2023 financial results

Generated total revenues of $110.4 million in the third quarter, including $75.3 million for SYFOVRE® (pegcetacoplan injection) and $23.9 million for...

November 1, 2023, 11:05 am

Springworks therapeutics announces presentation of additional data from phase 3 defi trial of nirogacestat in adults with desmoid tumors at the 2023 ctos annual meeting

– Nirogacestat Treatment Demonstrated Rapid and Sustained Improvements in Functional Status Compared to Placebo Across Multiple Assessment Tools –...

November 1, 2023, 10:30 am

Genetic toxicology testing market expected to reach a market value of us$ 4.56 billion: growing demand for personalized medicine spurs growth, according to persistence market research

The global genetic toxicology testing market is expected to grow rapidly in the coming years, driven by increasing demand from the ...

November 1, 2023, 10:04 am

Apellis pharmaceuticals, inc. (apls) reports q3 loss, tops revenue estimates

Apellis pharmaceuticals, Inc. (APLS) came out with a quarterly loss of $1.17 per share versus the Zacks...

November 1, 2023, 9:46 am

What's in store for cardinal health (cah) in q1 earnings?

Cardinal Health's (CAH) first-quarter fiscal 2024 results are expected to reflect solid performance in the pha...

November 1, 2023, 9:01 am

Should you invest in the vaneck pharmaceutical etf (pph)?

If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the VanEck ...

November 1, 2023, 7:31 am

Atea pharmaceuticals to host third quarter 2023 financial results conference call on november 8, 2023

BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Atea pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a cli...

November 1, 2023, 7:00 am

Investor patience tested as pharmaceutical stocks take a tumble

The Health Care Select Sector SPDR Fund NYSEARCA: XLV was down 3.81% in the past month and 8.03% in the past three months. The latest round of ...

November 1, 2023, 6:07 am

Gsk raises outlook amid strong demand for new rsv vaccine

GSK PLC (LSE:GSK, NYSE:GSK) said a strong third quarter performance has driven a further upgrade to full-year guidance boosted by demand for its respi...

November 1, 2023, 3:31 am

Apnimed announces launch of joint venture with shionogi to develop novel pharmacologic therapies for obstructive sleep apnea and other sleep disorders

$150M transaction supporting early and clinical-stage pipeline development in OSA and related sleep disorders to find oral pharmacologic solutions for...

November 1, 2023, 12:00 am

Undervalued and ready to rise: 3 stocks to watch in 2024

Most stocks are down on the year and the major United States indices are endanger of giving up the gains they achieved this past spring as we progress...

October 31, 2023, 8:48 pm

Tonix shares sink 29% on discontinued development on depression treatment

Shares of Tonix pharmaceuticals TNXP fell Tuesday after the company said it would discontinue developme...

October 31, 2023, 8:16 pm

Amphastar pharmaceuticals (amph) rises yet lags behind market: some facts worth knowing

In the most recent trading session, Amphastar pharmaceuticals (AMPH) closed at $45.27, indicating a +0....

October 31, 2023, 6:47 pm

Lirum therapeutics presents positive data on lx-101, a novel clinical-stage targeted therapy, demonstrating potent preclinical activity against pediatric sarcomas

New York, NY, Oct. 31, 2023 (GLOBE NEWSWIRE) — Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage bio...

October 31, 2023, 5:27 pm

Mersana therapeutics to host third quarter 2023 conference call on november 7, 2023

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage bio...

October 31, 2023, 4:30 pm

Pfizer reports first quarterly loss since 2019

Shares of Pfizer (PFE) slipped after the pharmaceutical company reported its first quarterly loss since...

October 31, 2023, 3:02 pm

Kiniksa pharmaceuticals ltd (knsa) q3 2023 earnings call transcript

Kiniksa pharmaceuticals Ltd (NASDAQ:KNSA ) Q3 2023 Earnings Conference Call October 31, 2023 8:30 AM ET...

October 31, 2023, 2:35 pm

Pharma giant prepares for earnings call

pharmaceutical concern CVS Health Corp (NYSE:CVS) will enter the earnings confessional before the open...

October 31, 2023, 12:32 pm

Will intercept pharmaceuticals (icpt) report negative q3 earnings? what you should know

Intercept (ICPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with...

October 31, 2023, 11:17 am


Search within

Pages Search Results: